The teams that lost first-round players will be looking for the next man up. Here's who should take over for those 32 picks.
Mirai Bio, the innovation delivery partner for companies developing next generation nucleic acid medicines, today announced that it will present three abstracts at ASGCT 2026, including one oral ...
China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results